ArticleJournal of clinical practice and research2023
Comparing Pediatric and Adult Primary Chest Wall Tumors.
Article in Journal of clinical practice and research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aims to evaluate the differences in surgical interventions and outcomes for primary chest wall tumors in pediatric and adult patient groups. Materials and Methods: We reviewed records of patients operated on for primary chest wall tumors from January 2005 to June 2019. Patients aged 18 and younger were classified as pediatric (group I), while those above 18 were considered adults (group II). We analyzed demographic characteristics, histopathologic diagnosis, number of resected ribs, prosthetics requirements, complications, chemotherapy and radiotherapy applications, and related complications. The Kaplan-Meier method was used to analyze patient survival times, and the log-rank test was employed for comparing survival times between groups. Results: Of the 71 patients who underwent operations for primary chest wall tumors in our clinic between January 2005 and June 2019, 20 were pediatric (28.2%) and 51 were adults (71.8%). The 5-year overall survival rates for pediatric and adult patients were 72.9% and 68.8%, respectively (p=0.683), while the 5-year disease-free survival rates were 76.0% and 69.0%, respectively, showing no significant differences (p=0.709). Conclusion: Our findings indicate no significant differences between pediatric and adult primary chest wall tumors regarding disease-free survival times, overall survival rates, and surgical complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.